je.st
news
Tag: drug
Merck Announces FDA Acceptance of New Drug Application for Vorapaxar, Investigational Anti-Thrombotic Medicine
2013-07-24 14:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the New Drug Application (NDA) for its investigational anti-thrombotic medicine, vorapaxar, has been accepted for standard review by the U.S. Food and Drug Administration (FDA). Merck is seeking FDA approval of vorapaxar for the secondary prevention of cardiovascular events in patients with a history of heart attack and no history of stroke or transient ischemic attack (TIA). About Merck Language: English Contact: MerckMedia:Pamela Eisele, (908) 423-5042orPatrick Witmer, (267) 305-4910orInvestor:Carol Ferguson, (908) 423-4465orJustin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: application
medicine
drug
acceptance
China widens drug industry probe, visits Belgium's UCB
2013-07-19 12:09:22| Biotech - Topix.net
Belgian drugmaker UCB has been visited by Chinese authorities as the country widens investigations into bribery by drugmakers, following allegations against Britain's GlaxoSmithKline.
Tags: china
industry
drug
visits
Ensemble Therapeutics And Alexion Initiate Collaboration To Discover Macrocycle Drug Candidates Targeting Patients With Severe And Ultra-Rare Disorders
2013-07-18 09:30:00| drugdiscoveryonline Home Page
Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of small molecule therapeutics with the potential to modulate targets typically addressed by biologics, recently announced the initiation of a drug discovery collaboration with a subsidiary of Alexion Pharmaceuticals, Inc., the global biopharmaceutical company focused on developing and commercializing life-transforming therapies for patients with life-threatening, ultra-rare disorders
Tags: drug
discover
patients
collaboration
Merck: FDA cancels panel meeting on surgery drug
2013-07-16 22:00:10| Biotech - Topix.net
Inc. said Tuesday that the Food and Drug Administration has cancelled a Thursday meeting to review its drug designed to help patients "wake up" after surgery with anesthesia.
Tags: meeting
panel
drug
surgery
GlaxoSmithKline accused of being 'ringleader' in massive China drug sales bribery scandal
2013-07-15 20:12:22| Biotech - Topix.net
Note: We do not store your email address but your IP address will be logged to prevent abuse of this feature.
Tags: sales
china
drug
massive
Sites : [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] next »